India Expands Price Caps on 137 Cancer Medicines by Up to 70 Percent
· India · Telegraph India, LiveMint
The Indian government has capped trade margins on 137 anti-cancer drugs, reducing their costs by up to 70 percent effective from November 9. The policy revision targets essential oncological treatments to make critical therapies more affordable for patients across the country. The move follows ongoing evaluations of high out-of-pocket medical expenses for chronic illnesses in India. Regulatory authorities will monitor pharmaceutical distributors and retail outlets to ensure compliance with the revised pricing caps.
Why it matters
Cancer patients and their families across India will face significantly lower out-of-pocket expenses for essential anti-cancer medications.
Read the original report — Telegraph India
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.